Form 424B5 - Prospectus [Rule 424(b)(5)]
01 Marzo 2024 - 3:30PM
Edgar (US Regulatory)
Filed
Pursuant to Rule 424(b)(5)
Registration
No. 333-262311
PROSPECTUS
SUPPLEMENT
(To
Prospectus dated February 1, 2022
and
Prospectus Supplement dated February 4, 2022) |
February
28, 2024 |
Up
to $50,000,000
Beyond
Air, Inc.
Common
Stock
This
prospectus supplement (the “Supplement”) supplements the prospectus supplement (the “Prospectus Supplement”),
dated February 4, 2022, providing for the offer and sale of shares of our common stock, par value $0.0001 per share, having an aggregate
offering price of up to $50,000,000 from time to time through the agents named therein. Sales of our common stock, if any, under this
Supplement, the Prospectus Supplement and the base prospectus will be made by any method that is deemed to be an “at the market
offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended. This Supplement should be read
in conjunction with the Prospectus Supplement, the base prospectus, and any additional prospectus supplement or amendment.
This
Supplement is being filed to reflect the amendment of the at-the-market equity offering sales agreement
with Truist Securities, Inc. and Oppenheimer & Co. Inc., pursuant to which the offering is being conducted, to remove Oppenheimer
& Co. Inc.
Accordingly,
each reference in the Prospectus Supplement to the term “agents” or “sales agents” is hereby amended to remove
Oppenheimer & Co. Inc.
In
addition, the list of agents on the front cover of the Prospectus Supplement is hereby amended and restated as follows:
Truist
Securities
In
addition, the list of agents on the back cover of the Prospectus Supplement is hereby amended and restated as follows:
Truist
Securities
Beyond Air (NASDAQ:XAIR)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Beyond Air (NASDAQ:XAIR)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024